Login / Signup

R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study.

Rose J HartDarren BurnsBram L T RamaekersShijie RenDaniel GladwellWilliam G SullivanNiall J DavisonOwain SaundersIndeg SlyTheresa CainDawn Lee
Published in: PharmacoEconomics (2021)
The findings of this explicit comparison are used to produce recommendations for when R might be more suitable than Excel in contemporary cost-effectiveness analyses. We conclude that selection of appropriate modelling software needs to consider case-by-case modelling requirements, particularly (i) intended audience, (ii) complexity of analysis, (iii) nature and frequency of updates and (iv) anticipated model run time.
Keyphrases
  • data analysis
  • clinical evaluation